July 16, 2020
Westlaw Journal Intellectual Property
Although a party need not have Article III standing to appear before the Patent Trial and Appeal Board (PTAB), it must establish standing when appealing an adverse PTAB decision to the Federal Circuit. Building on the reasoning in a line of cases following GE, JTEKT, and AVX, the Federal Circuit has further elaborated on the particular standing requirements a party must meet to maintain an appeal. For instance, recently in Pfizer, Argentum, and Grit Energy, the Court closely examined the evidence required to show injury based on economic harm or infringement risk, and stressed that the appellant must prove that standing exists at the outset of the appeal and at all later stages.
In this article, Finnegan attorneys Mike Flibbert and Michelle Rice review the Federal Circuit’s analysis in recent standing cases, and provide practical considerations for parties seeking to establish, or refute, standing to appeal PTAB decisions.
Read the full article here.
©2020 Thomson Reuters. Originally published by Westlaw Journal Intellectual Property. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Articles
Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing
April 24, 2026
At the PTAB Blog
Federal Circuit PTAB Appeal Statistics for December 2025 - February 2026
March 31, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.